Top Growth Trends in the Artificial Intelligence (AI) In Respiratory Diseases Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Respiratory Diseases Market?
The escalation of environmental pollution is set to boost the advancement of artificial intelligence (AI) within the respiratory disease market. This type of pollution involves the accumulation of substances or energy forms more rapidly than they can be scattered or stored in a safe manner. AI has the ability to considerably lessen the effects of environmental pollution on respiratory health, providing real-time monitoring, personalized risk evaluations, informed decision-making, and groundbreaking solutions for both individuals and communities. For example, the US Energy Information Administration – a government agency in the States, reported that in June 2024, the CO2 emissions for 2021 were 35.72 billion metric tons, escalating to 38.5 billion metric tons in 2022. This indicates that the growing issue of environmental pollution is propelling the progression of AI in the respiratory disease market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
#What Growth Opportunities Will Drive the Artificial Intelligence (AI) In Respiratory Diseases Market’s CAGR Through 2034?
The market size of artificial intelligence (AI) in respiratory diseases has seen significant expansion in recent times. Its growth is projected to escalate from $7.66 billion in 2024 to $8.05 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical growth can be linked to factors such as stringent government regulations, amplified concerns about the environment, rising aging population, expansion in patient-centric healthcare strategies, and a boom in healthcare infrastructure development.
The market size for artificial intelligence (AI) in respiratory diseases is projected to experience a robust expansion in the forthcoming years, reaching a value of $9.85 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this surge during the forecast period include an increasing occurrence of respiratory diseases, the escalating demand for early recognition and treatment, the growth in environmental pollution, mounting healthcare expenditure, and research and development initiatives. Notable trends for the forecast period encompass technological innovations, drug discovery and development, customized treatment methods, telemedicine, and remote patient monitoring.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
What Are the Key Market Innovations in theArtificial Intelligence (AI) In Respiratory Diseases Market Over the Coming Years?
Prominent entities in the domain of artificial intelligence (AI) within the respiratory diseases market are introducing ground-breaking products like N-Tidal devices to monitor the tidal breathing of patients. The N-Tidal device calculates the volume of air transferred during normal breathing, delivering critical insights into lung function. TidalSense, a British respiratory technology firm, unveiled N-Tidal in August 2023 for example – a controlled AI technology for diagnosing and managing chronic obstructive pulmonary disease (COPD). The technology syncs N-Tidal’s CO2 sensor data with an AI platform to evaluate alterations in lung function, with a goal to enhance COPD diagnosis and management. The demonstrated high accuracy of the technology in clinical trials is poised to revolutionize the diagnostic methods for respiratory diseases. This launch marks a notable progress in the application of AI for assessing respiratory diseases, presenting a more convenient and effective replacement to current diagnostic examinations.
Who Are the Top Companies Driving Innovation and Growth in theArtificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Artificial Intelligence (AI) In Respiratory Diseases Market and Drive Its Revenue Growth?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Which Regions Are Emerging as Leaders in the Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2025, By The Business Research Company:
Artificial Intelligence in Healthcare Global Market Report 2024
Artificial Intelligence Services Global Market Report 2024
Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
